GlobeNewswire Inc.··NaGreenwich LifeSciences Faces Nasdaq Compliance Warning Over Delayed 10-K Filing
$GLSI receives Nasdaq compliance notice for late Form 10-K filing; stock remains tradable as company works with auditors on submission.
GLSIbiopharmaceuticalPhase III clinical trial